Imperial Recognized as 2026 National Best and Brightest Company to Work For! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Category:

Clinical Trial Business Insights

    Clinical Trial Business Insights

    Today’s Forecast: 5 Predictions About the Future of Clinical Trials

    by William McEwen May 20, 2020
    written by William McEwen

    There is a popular saying: “It’s difficult to make predictions, especially about the future.” Correct, but that didn’t stop me from asking Imperial leadership for their thoughts on what we might see in the years to come.

    Balancing innovation and risk

    The COVID-19 pandemic has created a phenomenon impacting both personal and professional lives — “COVID Time.” In COVID Time, we are seeing many aspects of our personal lives slow down, become more home and family centered, and making us acutely aware of the blessings that the world provided during normal times. Professionally, especially in the world of clinical research, the opposite is happening. We are experiencing a rapid acceleration of time. The race for testing and vaccines has driven down bureaucracy for the sake of critical efficiency. There is NO TIME to spare. It has done something else which is truly profound. It has forced the industry to move outside of its comfort zone after years of resisting, fumbling, and bumbling. We no longer have any option than to embrace technology and other unconditional approaches to decentralize clinical research away from the study site. If the patient can’t come to the trial, we have to bring the trial to the patient, and that is what is happening in record time. Protocol rewrites and approvals are taking place, with visits to the study site replaced by telemedicine, visiting study nurses, video conferences, remote diagnostics, supply chain workarounds, and much more. My original pre-pandemic contribution to this blog post had me predicting a much longer, but successful breakthrough of these approaches to streamline and decentralize research. Perhaps some incremental progress in 2020. Instead we are blasting forward at record pace. If there is a silver lining to COVID-19, it may be that it came with a time machine — and entrance was mandatory.

    Dan McDonald, vice president, global business development

    No recruitment challenges or attrition rate issues

    I predict a point where there is no such thing as poor attrition rates or issues with recruitment for trials. Why? Because they will be designed completely around the inclusion of the patient. More importantly, trials will become a part of life and something almost every person in the world will be on at any given time. Clinical trials are by nature a study of humans and our responses to treatments, products, or drugs, so I predict most people will access innovative treatment by trials.

    Imogen Cheese, Imperial director of business development, U.K. and Europe

    Expanded-purpose wearables

    Wearables will be developed that notify patients and EMS services of precursors to adverse events. They will interface with the patient’s autonomous driving system to redirect the passenger to the nearest ER or safe location for the intervention of EMS services.

    Steve Swanson, Imperial president and COO

    Gene counselors and genetic testing

    We continue to expand our understanding of how disease states and genetics play a role in patient care and outcomes. Even with the added complications from introducing another data set into clinical trials, we will see more genetic-specific results come from future clinical trials. Genetic screening will help create more effective therapies targeted to the genetic underlying cause of the disease. As clinical trials continue to evolve, we will see the need for more and more gene counselors to help support not only the patients and families involved with the clinical trial, but also in assisting researchers in patient recruitment and retention. Overall, this will lead to targeted therapies and better outcomes.

    Ryan Seeley, facility manager

    Research project managers and coordinators will be able to work in their native language

    With the shortage of clinical research associates (CRAs) and other positions that require working with others globally, losing the need for proficiency in the sponsor’s language could open up new pools of qualified candidates. So much of the communication needed to coordinate the everyday aspects of a clinical trial revolve around status updates and regularly passing along the same type of information.

    Advances in artificial intelligence and its ability to replicate the predictable aspects of human communication (we are far more predictable than people choose to believe) make it possible to someday be able to use localized versions of web portals to check the status of a trial as well as machine translation for the everyday email traffic we currently live in.

    Erica Manning, Imperialoperations manager of design, translation, and study closure services

    May 20, 2020 0 comments
    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsTranslation of Clinical Trial Materials

    Google Translate: The Unwitting Confidentiality Flaw

    by Sian Lukaszewicz April 15, 2020
    by Sian Lukaszewicz April 15, 2020

    The Information Age has impacted a wide range of industries and workplaces. The translation industry has been no stranger to technological advancements, predominantly with the introduction and ever increasing use of machine translation. The most renowned translation software is Google Translate. Launched in April 2006, …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Imperial’s Dan McDonald Receives Industry Honor

    by William McEwen March 18, 2020
    by William McEwen March 18, 2020

    We in the clinical trials industry are a community made up of countless numbers of people from thousands of companies. Even among our competitors, we are one family, united in our roles in the in the day-to-day lives (health!) of men, women, and children everywhere. …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Report from SCOPE Summit 2020

    by Imogen Cheese March 12, 2020
    by Imogen Cheese March 12, 2020

    Conferences can be indicative of the mood in an industry. They set the stage for what is to come, and also the issues and challenges being faced at that very moment. SCOPE Summit 2020 in Orlando was no exception to that rule. There was a …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Our Best Blog Posts of 2019

    by William McEwen January 15, 2020
    by William McEwen January 15, 2020

    Happy 2020 from Imperial Clinical Research Services! In welcoming the New Year, it’s a good time to reflect on the highlights of 2019 and look ahead to new opportunities. Imperial proudly provides clinical research-oriented blogs and ebooks provided by our diverse and knowledgeable subject matter …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsClinical Trial Materials Development and PrintingParticipant Engagement

    Plain Language – It’s for everyone

    by William McEwen October 24, 2019
    by William McEwen October 24, 2019

    According to the Institute of Medicine, there is a significant disparity between the health information people receive and actually understand. Even those in the health care industry can become vulnerable to not comprehending health information. When experiencing poor health or worry and stress about an …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    Site Motivation: A Key to Study Success

    by Hope Cullen September 25, 2019
    by Hope Cullen September 25, 2019

    Motivating clinical research sites is one of the most overlooked factors in the pharmaceutical research industry. Even when sponsors and CROs do acknowledge the issue, they are often at a loss for workable solutions. This is precisely the reason Imperial offers site surveys, interviews, and …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsClinical Trial Materials Development and Printing

    Erica Manning: From One Trial to Another

    by William McEwen August 29, 2019
    by William McEwen August 29, 2019

    This year, the Imperial Clinical Research Services blog is featuring professional insights from some of the women leaders in our company. I sat down for a discussion with Erica Manning, who is the manager of Imperial’s creative and translation services teams, to learn about her …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    DIA 2019: Connections, Selfies, and Bridging the Gap

    by Dan McDonald July 18, 2019
    by Dan McDonald July 18, 2019

    The Imperial Clinical Research Services business development team recently attended the Drug Information Association (DIA) Global Annual Meeting in San Diego. The DIA Annual Meeting gathers stakeholders across the drug development industry spectrum, from sponsors to contract research organizations, research sites and service providers, such …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Coping with Change

    by Andrea Balahoski July 16, 2019
    by Andrea Balahoski July 16, 2019

    Change: Recognize the Challenges and Dive In Change is difficult for most. And why shouldn’t it be? We’re all hard-wired to like certainty in most situations. We prefer our usual morning routine, and going to the office where we work in our normal workspace with …

    0 FacebookTwitterLinkedinEmail
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 20

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email Rss

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Clinical Trial Supplies and Equipment (44)
  • Clinical Trial Business Insights (198)
  • Clinical Trial Materials Development and Printing (55)
  • Participant Engagement (113)
  • Translation of Clinical Trial Materials (21)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribetoourblogandgetthelatestupdates,insights,andindustrytrendsdeliveredstraighttoyourinbox.Stayinformedandnevermissapost.

 

 


Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace